Define Your Path to Market Success

Navigating today’s complex pricing and reimbursement landscape requires strategic foresight, deep market intelligence, and the ability to balance global ambition with local realities. Our Market Access and Pricing Strategy services help you define the optimal route to market, position your innovation competitively, and secure sustainable value from early development through commercial launch. 

Strategic Planning and Development

Early Opportunity Assessment 

Evaluate commercial viability and market potential before committing resources. We conduct go/no-go analyses, target product profile refinement, and early pricing and reimbursement opportunity assessments to inform strategic decision-making and optimize development pathways. 

 

Market Access Strategy Development Build comprehensive roadmaps that align clinical development, regulatory pathways, and commercial objectives with payer and HTA requirements. Strategies address stakeholder mapping, evidence generation, reimbursement positioning, and cross-functional alignment to de-risk access and optimize outcomes. 

 

Global and Regional Strategic Planning 

Harmonize market access approaches across regions while respecting local market dynamics. Whether developing global value frameworks or country-specific strategies, we ensure consistency in messaging and flexibility in execution. 

 

Early Access Program Assessment and Strategy 

Evaluate opportunities for compassionate use, managed access programs, and pre-approval access schemes. Our assessments identify feasible pathways, regulatory requirements, and strategic implications to accelerate patient access while building evidence and stakeholder relationships. 

Launch and Commercialization

Launch Strategy and Sequencing 

Design phased market entry plans that prioritize high-value markets while managing risk. Our launch strategies account for regulatory timelines, payer readiness, competitive dynamics, and stakeholder engagement to accelerate time-to-access and maximize commercial potential. 

 

Pricing Analytics 

Develop evidence-based pricing strategies through willingness-to-pay studies, benchmarking analyses, and revenue forecasting. We model pricing scenarios across markets to identify optimal price points that balance payer acceptance, competitive positioning, and revenue objectives. 

 

Pricing Strategy Development 

Navigate emerging pricing pressures — including geopolitical changes and Most-Favored-Nation (MFN) policies — with creative solutions including outcomes-based agreements, risk-sharing schemes, and value-based contracting models. We design, test, and implement innovative pricing approaches tailored to your product, therapeutic area, and target markets. 

Why It Matters

Poor market access planning can cost up to 60% of a product’s potential value. The right strategy, implemented early, unlocks: 

Without Strategic Planning: 

  • Delayed time-to-market and time-to-reimbursement 
  • Suboptimal pricing and restrictive coverage decisions 
  • Unmanaged development and access risks 
  • Weak competitive differentiation 
  • Poor cross-functional alignment leading to inefficiencies

 

Strategic Market Access Delivers: 

  • Faster time-to-market and time-to-reimbursement
  • Optimal pricing and reimbursement outcomes
  • Reduced development and access risks
  • Stronger competitive differentiation
  • Improved cross-functional alignment

 

Only 30% of innovations meet or exceed revenue expectations at launch.

Success depends on broad market access, deep understanding of market needs, and clear product differentiation. Exactly what our strategies deliver. 

Our Approach

We combine global strategic vision with local market expertise to create tailored solutions that work in practice, not just on paper.

Our teams bring: 

  • Proven experience across all therapeutic areas, from rare diseases to oncology to cell and gene therapies, supporting over 200 successful launches in the past 5 years 
  • Deep relationships with payers, HTA bodies, and healthcare stakeholders across a variety geographies 
  • Integration with regulatory affairs and clinical development to align strategy across the product lifecycle 
  • Real-world insight into evolving access challenges, including Joint Clinical Assessments, the Inflation Reduction Act, and innovative therapy pathways 

 

From concept to commercialization, we help you make the right decisions at the right time—capturing value, accelerating access, and positioning your innovation for long-term success. 

 

Ready to optimize your market access strategy?

Contact us to discuss your path to market.